Skip to main content
. 2016 Jun 15;17(6):946. doi: 10.3390/ijms17060946

Figure 12.

Figure 12

Structures of kynurenine (62), (S)-(4-ethylsulfonyl) benzoylalanine hydrochloride ((S)-ESBA) (63) and its racemic mixture (64). The form of kynurenine that was used in designing inhibitors is highlighted by a polygon. The amino group, which plays a key role in stereoselectivity of ESBA in racemic mixtures is indicated by a circle.